NANOBIOANÁLISIS
NBA


Hospital Universitari Germans Trias i Pujol
Barcelona, EspañaPublications in collaboration with researchers from Hospital Universitari Germans Trias i Pujol (8)
2024
-
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance
Journal of Clinical Oncology, Vol. 42, Núm. 27, pp. 3247-3256
-
High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience
HemaSphere, Vol. 8, Núm. 12
-
Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial
Haematologica, Vol. 109, Núm. 12, pp. 4056-4066
2023
-
Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients
Haematologica, Vol. 108, Núm. 10, pp. 2753-2763
2022
-
RICORS2040: The need for collaborative research in chronic kidney disease
Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387
2019
-
Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myeloma
Blood, Vol. 134, Núm. 16, pp. 1337-1345
2014
-
Lymphomatoid granulomatosis of central nervous system and lung driven by Epstein Barr virus proliferation: Successful treatment with rituximab-containing chemotherapy
Mediterranean Journal of Hematology and Infectious Diseases, Vol. 6, Núm. 1
1999
-
ras Gene mutations in ethmoid sinus adenocarcinoma: Prognostic implications
Cancer, Vol. 86, Núm. 2, pp. 255-264